2013-06 | Prevalence and incidence of rheumatoid arthritis in South Korea | 최찬범 |
2016-09 | Prevalence and possible causes of hypouricemia at a tertiary care hospital | 최찬범 |
2016-01 | Progress in defining clinically meaningful changes for clinical trials in nonrenal manifestations of SLE disease activity | 최찬범 |
2014-03 | The Reliability and Validity of a Korean Translation of the ASAS Health Index and Environmental Factors in Korean Patients with Axial Spondyloarthritis | 최찬범 |
2014-06 | THE RISK FACTORS FOR NONADHERENCE TO ANTI-RHEUMATIC TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS | 최찬범 |
2014-06 | SAFETY OF TNF INHIBITORS AND PREDICTORS OF ITS DISCONTINUATION IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS | 최찬범 |
2014-09 | SKI306X inhibition of glycosaminoglycan degradation in human cartilage involves down-regulation of cytokine-induced catabolic genes | 최찬범 |
2014-06 | SURVIVAL AND PROGNOSTIC FACTORS IN PATIENTS WITH CONNECTIVE TISSUE DISEASE-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION: RESULTS FROM A KOREAN NATIONWIDE REGISTRY | 최찬범 |
2017-09 | Survival and prognostic factors in patients with connective tissue disease-associated pulmonary hypertension diagnosed by echocardiography: results from a Korean nationwide registry | 최찬범 |
2013-06 | TREATMENT AND OUTCOMES OF RHEUMATOID ARTHRITIS PATIENTS WITH HEPATITIS B | 최찬범 |
2012-11 | Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries | 최찬범 |
2017-01 | What factors affect discordance between physicians and patients in the global assessment of disease activity in rheumatoid arthritis? | 최찬범 |
2011-09 | 류마티스관절염 환자에서 의료보험 급여지침 변화가 생물학적 제제 단기 지속율에 미치는 영향 | 최찬범 |
2014-04 | 류마티스관절염에서 DAS28에 근거한 보험급여기준 적용시 항 TNF제제 대상 환자 예측 | 최찬범 |
2012-06 | 장피부 누공을 동반한 베체트 장염 환자를 Adalimumab으로 치료한 1예 | 최찬범 |
2011-12 | 한국인 류마티스관절염 환자에서 항 TNF 제제의 지속성에 관한 연구 | 최찬범 |
2016-02 | 한국인 류마티스관절염과 골관절염 환자의 위장관위험인자와 비스테로이드항염제 사용 비교 | 최찬범 |
2015-08 | 항 Tumor Necrosis Factor 제제 사용 전 잠복결핵 진단전략에 따른 결핵 발생률 | 최찬범 |